| Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity K Vriens, S Christen, S Parik, D Broekaert, K Yoshinaga, A Talebi, ... Nature 566 (7744), 403-406, 2019 | 267 | 2019 |
| Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ... The Journal of pathology 223 (1), 72-80, 2011 | 257 | 2011 |
| Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 164 | 2021 |
| MicroRNA-200 family modulation in distinct breast cancer phenotypes MÁ Castilla, J Díaz-Martín, D Sarrió, L Romero-Pérez, MÁ López-García, ... PloS one 7 (10), e47709, 2012 | 112 | 2012 |
| ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma L Romero-Pérez, MÁ López-García, J Díaz-Martín, M Biscuola, ... Modern Pathology 26 (11), 1514-1524, 2013 | 76 | 2013 |
| Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer J Diaz-Martin, MÁ López-García, L Romero-Perez, MR Atienza-Amores, ... Endocrine-related cancer 22 (3), 443-454, 2015 | 68 | 2015 |
| VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer MÁ Castilla, MÁ López-García, MR Atienza, JM Rosa-Rosa, J Díaz-Martín, ... Endocrine-related cancer 21 (4), 587-599, 2014 | 54 | 2014 |
| Improving the management of Inherited Retinal Dystrophies by targeted sequencing of a population-specific gene panel N Bravo-Gil, C Méndez-Vidal, L Romero-Pérez, M González-del Pozo, ... Scientific reports 6 (1), 1-10, 2016 | 53 | 2016 |
| Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes J Musa, F Cidre-Aranaz, MM Aynaud, MF Orth, MML Knott, O Mirabeau, ... Nature communications 10 (1), 4128, 2019 | 49 | 2019 |
| DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma C Koelsche, M Kriegsmann, FKF Kommoss, D Stichel, K Kriegsmann, ... Journal of cancer research and clinical oncology 145, 1273-1281, 2019 | 48 | 2019 |
| STAG mutations in cancer L Romero-Pérez, D Surdez, E Brunet, O Delattre, TGP Grünewald Trends in cancer 5 (8), 506-520, 2019 | 38 | 2019 |
| Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis L Romero-Pérez, MÁ Castilla, MÁ López-García, J Díaz-Martín, ... Human pathology 44 (2), 244-254, 2013 | 37 | 2013 |
| A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas MF Orth, VL Buecklein, E Kampmann, M Subklewe, E Noessner, ... Cancer Immunology, Immunotherapy 69, 1353-1362, 2020 | 32 | 2020 |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ... Nature Communications 11 (1), 2423, 2020 | 31 | 2020 |
| Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma Clinical Cancer Research, 2018 | 31* | 2018 |
| DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics FKF Kommoss, D Stichel, D Schrimpf, M Kriegsmann, B Tessier-Cloutier, ... Journal of cancer research and clinical oncology 146, 97-104, 2020 | 29 | 2020 |
| Oncogene alterations in endometrial carcinosarcomas M Biscuola, K Van de Vijver, MÁ Castilla, L Romero-Pérez, ... Human pathology 44 (5), 852-859, 2013 | 28 | 2013 |
| A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer L Romero-Pérez, P Garcia-Sanz, A Mota, S Leskelä, ... Modern Pathology 28 (11), 1492-1503, 2015 | 26 | 2015 |
| Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma M Dallmayer, J Li, S Ohmura, R Alba Rubio, MC Baldauf, TLB Hölting, ... Cell death & disease 10 (2), 116, 2019 | 19 | 2019 |
| Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients G Sannino, A Marchetto, A Ranft, S Jabar, C Zacherl, R Alba-Rubio, ... EBioMedicine 47, 156-162, 2019 | 18 | 2019 |
Thomas G. P. GrünewaldHopp-Children´s Cancer Center Heidelberg (KiTZ)Verified email at kitz-heidelberg.de
